| | | | | | | | | Sponsored | | Routine quality control plays a critical role in molecular women's health testing. Explore third-party, whole-organism NATtrol™ controls for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, and more. Available in ready-to-use liquid and swab formats. |
|
|
| | |
| |
| | |
|
|
| | | | | | MLO invites clinical laboratory professionals to participate in a quick survey on molecular diagnostics, with results to be featured in the upcoming November issue, offering valuable industry insights. The survey will remain open until September 15. |
|
|
| | A GLP-1 receptor could potentially help prevent CKMD in children, according to a Vanderbilt Health press release. Researchers from Vanderbilt, UTHealth Houston, and the University of North Carolina at Chapel Hill identified early signs of CKMD that the medication can reverse. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Upgrade your cobas® 6800/8800 systems to Software 2.0. Experience lightning-fast performance, improved user experience, and intelligent scheduling that eliminates manual sorting. Save time and costs with flexible, customizable QC intervals. Evolve your lab. |
|
|
| | |
| |
| | |
|
|
| | | | | | AstraZeneca recently received accelerated approval from the U.S. Food and Drug Administration for a new treatment option for patients with advanced breast cancer. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | At ADLM, Diasorin experts discuss diagnostic stewardship, decentralized testing, clinically appropriate diagnostics, & how innovative solutions help laboratories improve efficiency, reduce unnecessary testing, & support better patient outcomes. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Mass spectrometry is revolutionizing healthcare by providing more precise and reliable diagnostics. This innovative technology accurately measures complex biological samples, offering valuable insights to healthcare professionals. By improving diagnostic test accuracy, mass spectrometry supports better-informed decisions and more tailored, effective patient care. |
|
|
| | |
| |
| | |
|
|
| | | | | | Sapio Sciences announced that FairJourney Bio (FJBio) will replace spreadsheet-based records and manual reporting processes across its international operations using the Sapio Scientific AI Platform, including Sapio’s LIMS, ELN and AI co-scientist solutions. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
